Lee, Dong-Hwa <br/><br/>
Effect of sarpogrelate, a selective 5-HT  [electronic resource] 

 -  Atherosclerosis  02 2017 
 - 47-54 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1879-1484 
<br/><br/><label>Standard No.: </label>10.1016/j.atherosclerosis.2016.12.011  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Ankle Brachial Index<br/>Anti-Inflammatory Agents--therapeutic use<br/>Aspirin--therapeutic use<br/>Biomarkers--blood<br/>Computed Tomography Angiography<br/>Coronary Angiography--methods<br/>Coronary Artery Disease--blood<br/>Coronary Stenosis--complications<br/>Coronary Vessels--diagnostic imaging<br/>Diabetes Mellitus, Type 2--blood<br/>Drug Therapy, Combination<br/>Female<br/>Humans<br/>Insulin Resistance<br/>Male<br/>Middle Aged<br/>Multidetector Computed Tomography<br/>Plaque, Atherosclerotic<br/>Platelet Aggregation Inhibitors--adverse effects<br/>Pulse Wave Analysis<br/>Republic of Korea<br/>Serotonin 5-HT2 Receptor Antagonists--adverse effects<br/>Severity of Illness Index<br/>Succinates--adverse effects<br/>Time Factors<br/>Treatment Outcome<br/>Vascular Calcification--diagnostic imaging